V.B. Shatylo

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

RETRACTED: Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Pilot Study

Zoya Serebrovska, Viktor Kholin, Lesya V. Tumanovska et al. · International Journal of Molecular Sciences · 2019 · 88 citations · Full text

Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression

Tatiana V. Serebrovskaya, Alla G. Portnychenko, T. Drevytska et al. · Experimental Biology and Medicine · 2017 · 62 citations · Full text

Intermittent Hypoxia/Hyperoxia Versus Intermittent Hypoxia/Normoxia: Comparative Study in Prediabetes

Tatiana V. Serebrovskaya, Oksana N. Grib, Zoya Serebrovska et al. · High Altitude Medicine & Biology · 2019 · 31 citations

Effects of intermittent hypoxia training on leukocyte pyruvate dehydrogenase kinase 1 (PDK-1) mRNA expression and blood insulin level in prediabetes patients

Tatiana V. Serebrovskaya, Alla G. Portnychenko, Lei Xi et al. · European Journal of Applied Physiology · 2019 · 25 citations

Metabolic Syndrome, Health Sciences, Intermittent Hypoxia Training +11